INNOVAGE HLDG DL -,001 Logo
US45784A1043
A2QP90
INNV

INNOVAGE HLDG DL -,001

Caricamento quotazioni...

Previsioni

Il prezzo obiettivo medio degli analisti è 11,22 € (+19,74%). La mediana è 11,22 € (+19,74%).

Acquista
  1
Mantieni
  6
Vendi
  2

  • InnovAge names Jennifer Browne president and COO

    InnovAge has appointed Jennifer Browne as president and chief operating officer effective June 8, 2026. Browne joins from Strive Health and was previously senior vice president at Optum; she will oversee market operations and central support functions. The PACE provider serves about 8,050 participants, has a market capitalization of roughly $1.03 billion and generated $949 million in revenue over the past twelve months. Analysts forecast a return to profitability this year with expected earnings per share of $0.21. » Altro su de.investing.com


  • InnovAge misses EPS estimate badly, revenue rises 15.5%

    For Q3 2026 InnovAge reported EPS of -$0.22, missing the $0.05 expected by a wide margin, while revenue of $251.9 million beat forecasts by 7.4%. Adjusted EBITDA rose 182% to $30.5 million, but net loss widened to $29.9 million. The stock fell after hours; management remains optimistic and is focusing on AI and technology investments. For Q1 2027 the company forecasts EPS of $0.12 on expected revenue of $251.5 million. » Altro su de.investing.com


  • InnovAge increases revenue and margins despite Q3 net loss

    InnovAge reported Q3 2026 revenue of $251.9 million (+15.5% year‑over‑year) and a marked improvement in center‑level contribution margin. At the same time, the company posted a net loss of $29.9 million (‑$0.22 per share), while adjusted EBITDA was $30.5 million. The shares rose about 2.8% in after‑hours trading; management forecasts further revenue growth for Q4 2026 and Q1 2027 and a gradual improvement in EPS. Risks remain higher sales and marketing expenses and burdens from legal disputes. » Altro su de.investing.com

Dati finanziari dell'azienda

Nell'ultimo trimestre, INNOVAGE HLDG DL -,001 ha registrato ricavi pari a 217,65 Mln € e un utile netto di -25,45 Mln €
(EUR) mar 2026
YoY
Ricavi 217,65 Mln 7,94%
Utile lordo 48,55 Mln 28,89%
Utile netto -25,45 Mln 142,00%
EBITDA -20,7 Mln 395,99%

Dati fondamentali

Metrica Valore
Capitalizzazione di mercato
1,27 Mld €
Numero di azioni
135,74 Mln
Massimo/minimo a 52 settimane
10,91 € - 3,05 €
Dividendi No
Beta
0,40
Rapporto P/E
-67,16
Rapporto PEG
0,08
Rapporto P/B
6,43
Rapporto P/S
1,56

Profilo aziendale

InnovAge Holding Corp. verwaltet und bietet eine Reihe von medizinischen und ergänzenden Dienstleistungen für Senioren an, die Pflege und Unterstützung benötigen, um unabhängig in ihren Wohnungen und Gemeinden zu leben. Das Unternehmen verwaltet sein Geschäft nach dem Konzept des Program of All-Inclusive Care for the Elderly (PACE). Das Unternehmen bietet häusliche Pflegedienstleistungen an, die aus qualifizierter, ungelernter und persönlicher Pflege bestehen; Dienstleistungen in den Zentren, wie z. B. medizinische Grundversorgung, Physiotherapie, Beschäftigungstherapie, Sprachtherapie, zahnärztliche Dienstleistungen, geistige Gesundheit und psychiatrische Dienstleistungen, Mahlzeiten und Aktivitäten; Transport zum PACE-Zentrum und zu medizinischen Terminen Dritter; und Pflegemanagement. Das Unternehmen betreut rund 6 850 PACE-Teilnehmer in den Vereinigten Staaten und betreibt 18 PACE-Zentren in Colorado, Kalifornien, New Mexico, Pennsylvania und Virginia. Das Unternehmen war früher als TCO Group Holdings, Inc. bekannt und änderte im Januar 2021 seinen Namen in InnovAge Holding Corp. um. InnovAge Holding Corp. wurde 2007 gegründet und hat seinen Hauptsitz in Denver, Colorado.

Nome
INNOVAGE HLDG DL -,001
CEO
Patrick Blair
Sede centrale Denver, co
Stati Uniti
Sito web
Settore
Sanità
Industria
Fornitori e servizi sanitari
Quotazione in borsa
04/03/2021
Dipendenti 2440

Simboli di borsa

Borsa Simbolo
NASDAQ
INNV
🍪

Parqet  usa i cookie. Scopri di più